GSK3B and pancreatic neoplasm: In a recent preliminary study, we found that GSK3β inhibition counteracts tumor invasion and distant metastasis [Figure 2B] as well as the sphere formation of BxG400 cells, which acquire the highest resistance to gemcitabine established from the gemcitabine-sensitive pancreatic cancer BxPC-3 cells [Figure 2A].